A groundbreaking drug programme is set to target endometriosis using a novel Jun-N-terminal kinase (JNK) inhibitor that targets pain and inflammation. The therapeutic drug candidate aims...
A groundbreaking Phase 1 clinical trial has explored a novel cell-based immunotherapy for breast cancer – a new treatment approach that aims to harness the body’s...